Head and Neck Cancer Survivorship Care: A Review of the Current Guidelines and Remaining Unmet Needs
- 599 Downloads
A larger proportion of patients with head and neck cancers (HNC) are now surviving, constituting up to 3% of all cancer survivors. This is likely due in part to the increase in HPV-related oropharyngeal cancers affecting younger individuals and with a better prognosis and to the improved outcomes of other HNCs as well over the last two decades. Most studies have previously been focusing on improving risk stratification, treatment and disease-related outcomes. Over the last decade, there has been an evolving interest in the field of survivorship care. Despite the collaborative efforts from a multidisciplinary team in managing cancer and treatment-related side-effects and in improving survivors’ overall quality of life (QOL), it has been reported that up to 60–65% of patients have at least one unmet need. The purpose of this article is to review current guidelines for HNC survivorship care and identify areas of unmet need. Over the last 5 years, multiple groups have published guidelines describing survivorship care issues and their possible management. Although a very comprehensive and informative first initiative, multiple issues need to be further evaluated. These include how to best support patients and their partners’ fear of cancer recurrence, to provide coordinated care among all physicians, to identify and meet patients’ needs in local multidisciplinary teams and to institute measures to ensure every individual’s access to high-quality patient-centred care. Furthermore, experts may consider engaging in further dialog with primary care physicians (PCP) to improve sharing of survivorship care. More should be learned about PCPs’ comfort levels in providing such care and whether further steps are required to facilitate a seamless. Transition of care and accessibility to specialized care as needed.
KeywordsHead-neck neoplasms Squamous cell carcinoma Cancer survivorship care Guidelines Systematic review
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
This material has never been published and is not under evaluation in other peer-reviewed publication.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance•• Of major Importance
- 1.Council. IoMaNR. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC. 2006.Google Scholar
- 3.Recommended breast cancer surveillance guidelines. Proc Am Soc Clin Oncol J Clin Oncologia 1997;15(5):2149–56. doi: 10.1200/JCO.1922.214.171.1249.Google Scholar
- 5.Khatcheressian JL, Wolff AC, Smith TJ, Grunfeld E, Muss HB, Vogel VG, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24(31):5091–7. https://doi.org/10.1200/JCO.2006.08.8575.CrossRefPubMedGoogle Scholar
- 6.Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(7):961–5. https://doi.org/10.1200/JCO.2012.45.9859.CrossRefPubMedGoogle Scholar
- 7.Resnick MJ, Lacchetti C, Bergman J, Hauke RJ, Hoffman KE, Kungel TM, et al. Prostate cancer survivorship care guideline: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2015;33(9):1078–85. https://doi.org/10.1200/JCO.2014.60.2557.CrossRefPubMedGoogle Scholar
- 9.Meyerhardt JA, Mangu PB, Flynn PJ, Korde L, Loprinzi CL, Minsky BD, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013;31(35):4465–70. https://doi.org/10.1200/JCO.2013.50.7442.CrossRefPubMedGoogle Scholar
- 11.Rosenberg-Yunger ZR, Klassen AF, Amin L, Granek L, D'Agostino NM, Boydell KM, et al. Barriers and facilitators of transition from pediatric to adult long-term follow-up care in childhood cancer survivors. J Adolesc Young Adult Oncol. 2013;2(3):104–11. https://doi.org/10.1089/jayao.2013.0003.CrossRefPubMedGoogle Scholar
- 13.Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children’s oncology group long-term follow-up guidelines from the Children’s oncology group late effects committee and nursing discipline. J Clin Oncol. 2004;22(24):4979–90. https://doi.org/10.1200/JCO.2004.11.032.CrossRefPubMedGoogle Scholar
- 18.•• Cohen EE, LaMonte SJ, Erb NL, Beckman KL, Sadeghi N, Hutcheson KA, et al. American Cancer Society head and neck cancer survivorship care guideline. CA Cancer J Clin. 2016;66(3):203–39. https://doi.org/10.3322/caac.21343. The first American Cancer Society guideline for Survivorship Care in head and neck cancer.CrossRefPubMedGoogle Scholar
- 19.•• (NCERG) NCERG. Optimal care pathway for people with head and neck cancers Cancer Council Australia; 2016. p. 60. The Australian carepath for head and neck cancer.Google Scholar
- 21.Nekhlyudov L, Lacchetti C, Davis NB, Garvey TQ, Goldstein DP, Nunnink JC, et al. Head and neck Cancer survivorship care guideline: American Society of Clinical Oncology clinical practice guideline endorsement of the American Cancer Society guideline. J Clin Oncol. 2017;35(14):1606–21. https://doi.org/10.1200/JCO.2016.71.8478.CrossRefPubMedGoogle Scholar
- 22.Siano M, Infante G, Resteghini C, Cau MC, Alfieri S, Bergamini C, et al. Outcome of recurrent and metastatic head and neck squamous cell cancer patients after first line platinum and cetuximab therapy. Oral Oncol. 2017;69:33–7. https://doi.org/10.1016/j.oraloncology.2017.04.002.CrossRefPubMedGoogle Scholar
- 25.Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol. 2014;32(17):1840–50. https://doi.org/10.1200/JCO.2013.53.4495.CrossRefPubMedPubMedCentralGoogle Scholar
- 26.National Comprehensive Cancer N. NCCN Distress Thermometer and Problem List for Patients. 2016. https://www.nccn.org/patients/resources/life_with_cancer/pdf/nccn_distress_thermometer.pdf. Accessed February 18, 2018 2018.
- 32.Giuliani M, Milne R, McQuestion M, Sampson L, Le LW, Jones J, et al. Partner’s survivorship care needs: an analysis in head and neck cancer patients. Oral Oncol. 2017;71:113–21. https://doi.org/10.1016/j.oraloncology.2017.06.011.CrossRefPubMedGoogle Scholar
- 33.Hodgkinson K, Butow P, Hobbs KM, Hunt GE, Lo SK, Wain G. Assessing unmet supportive care needs in partners of cancer survivors: the development and evaluation of the Cancer Survivors’ partners unmet needs measure (CaSPUN). Psychooncology. 2007;16(9):805–13. https://doi.org/10.1002/pon.1138.CrossRefPubMedGoogle Scholar
- 36.•• Ringash J, Bernstein LJ, Devins G, Dunphy C, Giuliani M, Martino R, et al. Head and Neck Cancer Survivorship: Learning the Needs, Meeting the Needs. Semin Radiat Oncol. 2018;28(1):64–74. https://doi.org/10.1016/j.semradonc.2017.08.008. A comprehensive overview of current needs and unmet needs in HNC survivors.CrossRefPubMedGoogle Scholar
- 39.Tromp DM, Brouha XD, Hordijk GJ, Winnubst JA, de Leeuw RJ. Patient and tumour factors associated with advanced carcinomas of the head and neck. Oral Oncol. 2005;41(3):313–9. https://doi.org/10.1016/j.oraloncology.2004.09.008.CrossRefPubMedGoogle Scholar
- 41.Eades M, Murphy J, Carney S, Amdouni S, Lemoignan J, Jelowicki M, et al. Effect of an interdisciplinary rehabilitation program on quality of life in patients with head and neck cancer: review of clinical experience. Head Neck. 2013;35(3):343–9. https://doi.org/10.1002/hed.22972.CrossRefPubMedGoogle Scholar
- 42.Passchier E, Stuiver MM, van der Molen L, Kerkhof SI, van den Brekel MW, Hilgers FJ. Feasibility and impact of a dedicated multidisciplinary rehabilitation program on health-related quality of life in advanced head and neck cancer patients. Eur Arch Otorhinolaryngol. 2016;273(6):1577–87. https://doi.org/10.1007/s00405-015-3648-z.CrossRefPubMedGoogle Scholar
- 44.Verdonck-de Leeuw IM, van Bleek WJ, Leemans CR, de Bree R. Employment and return to work in head and neck cancer survivors. Oral Oncol. 2010;46(1):56–60. https://doi.org/10.1016/j.oraloncology.2009.11.001.CrossRefPubMedGoogle Scholar
- 46.•Baxi S, Salz T, Xiao H, Atoria CL, Ho A, Smith-Marrone S et al. Employment and return to work following chemoradiation in patient with HPV-related oropharyngeal cancer. Cancers of the Head & Neck. 2016;1(4). doi: 10.1186/s41199-016-0002-0. A relatively large study that includes over 100 patients with HNC describing challenging aspects in returning back to work.Google Scholar
- 50.Martin L, Watanabe S, Fainsinger R, Lau F, Ghosh S, Quan H, et al. Prognostic factors in patients with advanced cancer: use of the patient-generated subjective global assessment in survival prediction. J Clin Oncol. 2010;28(28):4376–83. https://doi.org/10.1200/JCO.2009.27.1916.CrossRefPubMedGoogle Scholar
- 51.(CPAC); CPAC, Group CJA. Guide to implementing screening for distress, the 6th vital sign. Moving towards person-centered care. Toronto, ON: CPAC; 2009.Google Scholar
- 54.Rosenthal DI, Mendoza TR, Chambers MS, Asper JA, Gning I, Kies MS, et al. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck. 2007;29(10):923–31. https://doi.org/10.1002/hed.20602.CrossRefPubMedGoogle Scholar
- 55.Li M, Macedo A, Crawford S, Bagha S, W.; LY, Zimmerman C et al. Easier said than done: keys to successful implementation of the distress assessment and response tool (DART) program. J Oncol Pract/Proc Am Soc Clin Oncol 2015;12(5):e513-ee26. doi: https://doi.org/10.1200/JOP.2015.010066.
- 57.Lyu KX, Zhao J, Wang B, Xiong GX, Yang WQ, Liu QH, et al. Smartphone application WeChat for clinical follow-up of discharged patients with head and neck tumors: a randomized controlled trial. Chin Med J. 2016;129(23):2816–23. https://doi.org/10.4103/0366-6999.194635.CrossRefPubMedPubMedCentralGoogle Scholar
- 58.Denis F, Lethrosne C, Pourel N, Molinier O, Pointreau Y, Domont J, Bourgeois H, Senellart H, Trémolières P, Lizée T, Bennouna J, Urban T, el Khouri C, Charron A, Septans AL, Balavoine M, Landry S, Solal-Céligny P, Letellier C Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. J Natl Cancer Inst.2017;109(9). doi: 10.1093/jnci/djx029.Google Scholar
- 59.Excellence OCo. Building capacity in the health system to improve follow-up care for breast cancer patients. 2017. http://www.oce-ontario.org/news-events/news/2017/12/05/building-capacity-in-the-health-system-to-improve-follow-up-care-for-breast-cancer-patients. Accessed February 1, 2018 2018.
- 62.Brammer C, Dawson D, Joseph M, Tipper J, Jemmet T, Liew L, et al. Adult co-morbidity evaluation 27 scores of head and neck cancer patients using touch-screen technology: patient satisfaction and clinical verification. J Laryngol Otol. 2017;131(5):442–6. https://doi.org/10.1017/S0022215116009397.CrossRefPubMedGoogle Scholar